> ## Content Index
> Fetch the complete content index at: https://www.foodconsumer.org/llms.txt
> Use this file to discover other available public pages before exploring further.

# Chinese medicine helps acute myocardial infarction patients
- URL: https://www.foodconsumer.org/chinese_medicine_myocardial_infarction_082220120709/
- Published: 2012-08-22T20:08:00.000Z
- Updated: 2026-09-22T15:59:24.000Z
- Description: Among 334 acute myocardial infarction patients, 2.96 percent of those given Chinese medicine alongside Western treatment were re-hospitalized for angina within six months, against 7.88 percent of controls. Chest pain, sweating and insomnia also eased in the treated group.
- Author: Food Consumer
- Tags: Drug, Health News, #vivvo-import

By David LIu, PHD

Wednesday Aug 22, 2012 ([foodconsumer.org](http://www.foodconsumer.org/)) -- A Chinese study published on Aug 16, 2012 in the Chinese Journal of Integrative Medicine indicates using Chinese medicine together with Western medicine helps prevent death from myocardial infarction, nonfatal myocardial infarction, ischemic stroke, heart failure and shock.

The study led by W.H. Duan of China Academy of Chinese Medical Sciences in Beijing, China and colleagues showed that among patients with acute myocardial infarction, 2.96 percent of the study subjects who used Chinese Medicine were re-hospitalized due to angina during a six-month follow-up, compared to 7.88 percent among the control subjects who did not use Chinese medicine.

The study enlisted 334 acute myocardial infarction patients between 2007 and 2009 with 169 assigned to receive a combined therapy of Chinese medicine for at least one month and six months of Western medicine and the remaining controls to receive Western medicine only.

For the study, clinical data from all acute myocardial infarction patients were collected on age, gender, smoking status, medical history, infarction area, heart functional classification, Chinese Medicine scores, blood-stasis syndrome score. Primary end points included death, nonfatal myocardial infarction, and revascularization and secondary end-points included ischemic stroke, re-hospitalization due to angina, heart failure and shock.

At the end of the six months of follow-up, the Chinese medicine syndrome score and blood stasis syndrome in the intervention group were significantly lower than those in the control group. Particularly relieved in the study group were the symptoms of chest pain, spontaneous perspiration and insomnia.

Kaplan-Meier survival curve showed that the event-free survival rate of re-hospitalization due to angina during the six-month follow-up was higher in the study group than the control group.

It was also found that heart dysfunction and diabetes mellitus in acute myocardial infarction patients were associated with 60 and 76 percent respectively more likely to suffer end points, compared to those who did not have these conditions.

In contrast, Chinese Medicine, percutaneous coronary intervention and aniotensin converting enzyme inhibitors were associated respectively with 59, 65,and 46 percent reduced risk of death, nonfatal myocardial infarction, and revascularization, ischemic stroke, rehospitalization due to angina, heart failure and shock.